![Simon Lu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Simon Lu
Directeur/Membre du Conseil chez
ASCENTAGE PHARMA GROUP INTERNATIONAL
Fortune : 208 750 $ au 31/08/2026
Profil
Simon Dazhong Lu currently works at Ascentage Pharma Group International Co., Ltd., as Independent Non-Executive Director from 2018.
Dr. Lu also formerly worked at McGill University, as Director from 2016 to 2018, CEL Partners Co. Ltd., as Managing Director from 2008 to 2009, Shanghai NewMargin Ventures Investment Management Co. Ltd., as Partner & Investment Manager from 2002 to 2007, and Arthur Andersen Business Consulting Co. Ltd. (Shanghai), as Auditor.
Dr. Lu received his doctorate degree in 2010 from Nankai University and undergraduate degree in 1991 from Nankai University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/04/2026 | 48 937 ( 0,01 % ) | 208 750 $ | 31/08/2026 |
Postes actifs de Simon Lu
| Sociétés | Poste | Début |
|---|---|---|
| ASCENTAGE PHARMA GROUP INTERNATIONAL | Directeur/Membre du Conseil | 06/07/2018 |
Anciens postes connus de Simon Lu
| Sociétés | Poste | Fin |
|---|---|---|
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | 01/11/2018 |
CEL Partners Co. Ltd.
 CEL Partners Co. Ltd. Investment ManagersFinance CEL Partners is an active manager which invests in medium-sized Chinese companies in growing and government-promoted sectors where CEL brings strong industry expertise including environmental (renewable energy, clean transport, energy efficiency, waste recovery , water treatment), healthcare (medical supplies & equipment, OTC/TCM drugs, distribution, CRO services), agribusiness (agriculture machinery, fresh food, green/bio products, logistics/cold-chain/food safety), consumer (FMCG, specialized retail, luxury products, household appliances housing materials and furniture) and suppliers (specialized suppliers such as automotive and aerospace suppliers, automotive parts and services). The firm seeks to invest USD 4-15 million in fast-growing Chinese companies with sales of USD 20-150 million, in Chinese SMEs with development or acquisition plans in Europe and in European SMEs with strong development plans in China. CEL Partners takes minority stakes in their investee companies. They exit investments through trade sales and IPOs. | Directeur Général | 01/07/2009 |
Shanghai NewMargin Ventures Investment Management Co. Ltd.
 Shanghai NewMargin Ventures Investment Management Co. Ltd. Investment ManagersFinance NewMargin is a hands-on, value added manager which invests in high-growth China-based companies in a range of industrial sectors including information technology, healthcare and life sciences, and new material and environmental protection. The firm seeks to invest well managed companies, partnering with entrepreneurs early, sharing their expertise and helping them to execute their business strategies. They provide their investee companies with access to their network of industry experts, entrepreneurs, executives, professional service providers and venture capital funds throughout the world and seek exits in the form of IPOs and trade sales. | Directeur en chef des Investissements | 01/12/2007 |
Arthur Andersen Business Consulting Co. Ltd. (Shanghai) | Comptroller/Controller/Auditor | - |
Formation de Simon Lu
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
87
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai NewMargin Ventures Investment Management Co. Ltd.
Shanghai NewMargin Ventures Investment Management Co. Ltd. Investment ManagersFinance NewMargin is a hands-on, value added manager which invests in high-growth China-based companies in a range of industrial sectors including information technology, healthcare and life sciences, and new material and environmental protection. The firm seeks to invest well managed companies, partnering with entrepreneurs early, sharing their expertise and helping them to execute their business strategies. They provide their investee companies with access to their network of industry experts, entrepreneurs, executives, professional service providers and venture capital funds throughout the world and seek exits in the form of IPOs and trade sales. | Finance |
Nankai University
 Nankai University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CEL Partners Co. Ltd.
CEL Partners Co. Ltd. Investment ManagersFinance CEL Partners is an active manager which invests in medium-sized Chinese companies in growing and government-promoted sectors where CEL brings strong industry expertise including environmental (renewable energy, clean transport, energy efficiency, waste recovery , water treatment), healthcare (medical supplies & equipment, OTC/TCM drugs, distribution, CRO services), agribusiness (agriculture machinery, fresh food, green/bio products, logistics/cold-chain/food safety), consumer (FMCG, specialized retail, luxury products, household appliances housing materials and furniture) and suppliers (specialized suppliers such as automotive and aerospace suppliers, automotive parts and services). The firm seeks to invest USD 4-15 million in fast-growing Chinese companies with sales of USD 20-150 million, in Chinese SMEs with development or acquisition plans in Europe and in European SMEs with strong development plans in China. CEL Partners takes minority stakes in their investee companies. They exit investments through trade sales and IPOs. | Finance |
Arthur Andersen Business Consulting Co. Ltd. (Shanghai) | |
Ascentage Pharma Group International Co., Ltd.
 Ascentage Pharma Group International Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in discovering, developing and commercializing of therapies for hematological malignancies | Health Technology |
